Today: 1 July 2026
TSMC stock faces Monday test after Nvidia boss Jensen Huang says he needs “a lot of wafers”
2 February 2026
1 min read

TSMC stock faces Monday test after Nvidia boss Jensen Huang says he needs “a lot of wafers”

TAIPEI, Feb 2, 2026, 06:50 (GMT+8) — Premarket

  • Nvidia’s Jensen Huang pushed TSMC to boost chip production amid soaring AI demand stretching capacity.
  • TSMC wrapped up trading in Taipei at T$1,775, while its U.S.-listed shares finished at $330.56.
  • Investors await TSMC’s January sales figures, set for release on Feb. 10.

TSMC shares enter Monday’s session under the spotlight after a major customer publicly pushed for increased capacity over the weekend.

Huang’s comments carry weight since Nvidia is a key player in the AI hardware surge and relies heavily on TSMC’s cutting-edge manufacturing. When Nvidia signals a demand for increased supply, traders often interpret it as an immediate snapshot of incoming orders.

The timing couldn’t be more inconvenient. Taiwan equities return after the weekend, and the stock has been jittery over every detail about AI spending, chip shortages, and the expenses tied to expanding capacity.

In Taipei, shares of 2330.TW closed Friday, Jan. 30, down 1.66% at T$1,775. Over in New York, TSMC’s U.S.-listed American depositary receipts (ADRs), which track the Taiwan shares, dropped 2.7% to $330.56.

Huang told reporters late Saturday, “TSMC needs to work very hard this year because I need a lot of wafers,” referring to the silicon disks used for chips. He also noted, “We need a lot of memory this year,” highlighting supply constraints beyond just processors. Huang added that TSMC could more than double its capacity over the next decade. Reuters

Just a day earlier, Huang confirmed Nvidia plans a “huge” investment in OpenAI’s upcoming funding round, dismissing reports of any friction as “nonsense.” He expressed his appreciation for working with Sam Altman and signaled Nvidia’s role in the financing effort, underscoring how major AI labs remain focused on securing capital for expanded computing power. Reuters

TSMC has already started responding to the surge in demand. In its January earnings update, it projected capital expenditures for 2026 to hit between $52 billion and $56 billion. CEO C.C. Wei admitted the company was “very nervous” about going too far. Quilter Cheviot’s Ben Barringer put it bluntly: “TSMC ultimately benefits as the key manufacturer of all their chips.” Reuters

Still, risks abound. Policy uncertainty shadows the sector, and supply chains can be jolted by shifting regulations: the U.S. gave TSMC a yearly license to bring American chipmaking equipment into its Nanjing plant in China, but export controls keep evolving.

Taiwan’s economy outpaced expectations in the fourth quarter, the government reported Friday, driven by surging demand for AI and high-performance computing. Capital Economics noted that export demand should stay robust throughout the coming year.

TSMC investors will be watching closely on Feb. 10, when the company reports its January monthly sales. A solid number could calm nerves following Friday’s decline; a weaker result might prompt another round of selling.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • ASX 200 trails global indexes in 2026 as key healthcare names dive
    July 1, 2026, 3:42 AM EDT. The ASX 200 barely managed a gain of less than 2.8% for the 2026 financial year, outpaced by major overseas markets. The rise was negative after inflation. US stocks soared, with the S&P 500 up 20.8%, NASDAQ up 28.7%, and Europe's STOXX 600 climbing 19%. Losses for CSL-off 52%-and Cochlear, down almost 60%, weighed on the Australian market. Bank results were mixed; ANZ gained 16% but Commonwealth Bank and NAB lagged. 4D Medical stood out with strong returns while the rest of the market barely moved.
C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers
Previous Story

C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers

OCBC stock price drops in Singapore as metals rout jolts markets; earnings next
Next Story

OCBC stock price drops in Singapore as metals rout jolts markets; earnings next

Go toTop